Cardiovascular toxicity associated with angiogenesis inhibitors: a comprehensive pharmacovigilance analysis based on the fda adverse event reporting system database from 2014 to

HIGHLIGHTS

• who: Wei Cui from the Barts Heart Centre, United Kingdom University of Naples Federico II, Italy have published the research work: Cardiovascular toxicity associated with angiogenesis inhibitors: A comprehensive pharmacovigilance analysis based on the FDA Adverse Event Reporting System database from 2014 to, in the Journal: (JOURNAL)
• what: With regard to the outcomes of AEs, this study showed that cardiovascular AEs associated with angiogenesis inhibitors presented more death than other drugs, suggesting a greater impact on patients` prognosis. Similar to previous studies, this study demonstrated that hypertension was the most frequently reported cardiovascular AE based . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.